Global Health News and Research

RSS

CDC receives 2014 Franz Edelman Award for Achievement in Operations Research, Management Sciences

The U.S. Centers for Disease Control and Prevention (CDC), which collaborated with Kid Risk, Inc. to use analytics and operations research to combat the remaining pockets of polio around the world, tonight won the 2014 Franz Edelman Award for Achievement in Operations Research and the Management Sciences at a banquet sponsored by the Institute for Operations Research and the Management Sciences (INFORMS) in Boston.

1 Apr 2014

MADIT-CRT study: Boston Scientific CRT defibrillator reduces risk of death in mild heart failure patients

In the longest follow-up to date of cardiac resynchronization therapy (CRT) for mild heart failure patients, Boston Scientific Corporation's exclusively sponsored and landmark Multicenter Automatic Defibrillator Implantation Trial – Cardiac Resynchronization Therapy (MADIT-CRT) study demonstrated significant and sustained survival benefit for the indicated population.

31 Mar 2014

Nordion enters into definitive agreement to be acquired by Sterigenics

Nordion Inc., a leading provider of products and services to the global health science market, announced that it has entered into a definitive agreement (the "Arrangement Agreement") to be acquired by Sterigenics, a global leader in sterilization services and a portfolio company of GTCR LLC, a leading private equity firm based in Chicago, Illinois, USA.

29 Mar 2014

New policy report on multi-drug resistant tuberculosis

Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice’s multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.

28 Mar 2014

Economic growth has little to no effect on nutritional status of world's poorest children

A large study of child growth patterns in 36 developing countries finds that, contrary to widely held beliefs, economic growth has little to no effect on the nutritional status of the world's poorest children.

27 Mar 2014

ASU scientist selected as 2014 recipient of Lifetime Achievement Award

Roy Curtiss III, a scientist at the Biodesign Institute at Arizona State University, has been selected as the 2014 recipient of the Lifetime Achievement Award from the American Society for Microbiology.

26 Mar 2014

WHO report confirms air pollution as world's largest single environmental health risk

In new estimates released today, WHO reports that in 2012 around 7 million people died - one in eight of total global deaths - as a result of air pollution exposure. This finding more than doubles previous estimates and confirms that air pollution is now the world's largest single environmental health risk. Reducing air pollution could save millions of lives.

25 Mar 2014

IDRI awarded grant extension of $3.4M for identifying new leads and drug targets for tuberculosis

IDRI's drug discovery efforts continue to grow with a recently awarded grant extension of $3.4 million from the Bill & Melinda Gates Foundation. The additional funding was awarded to Tanya Parish, Ph.D., IDRI's Vice President of Drug Discovery, and supplements an earlier grant awarded in 2010, for a total of $7.8 million.

25 Mar 2014

Tuberculosis control needs a complete and patient-centric solution

Whether it is mobile phone service or vacation travel, good businesses know that success depends on providing a complete and customer-centric solution. Should patients with tuberculosis not be offered a complete solution that is patient-centered? After all, millions are affected and a large market at the base-of-the-pyramid (BoP) remains unserved.

24 Mar 2014

New national research consortium focuses on better drug therapies for viral infections

Viral infections with limited or no treatment options can pose a major global health threat, but a new national research consortium centered at the University of Alabama at Birmingham is focused on the discovery of new and better drug therapies as these viruses emerge.

24 Mar 2014

Researchers developing new medication to tackle river blindness and elephantiasis

Researchers are developing new drug treatments to tackle river blindness and elephantiasis, which affect up to 150 million people across the world.

24 Mar 2014

Study: Mood stabilizing drug may help prevent head and neck cancer

A new study indicates that a commonly used mood stabilizing drug may help prevent head and neck cancer. The study is published early online in Cancer, a peer-reviewed journal of the American Cancer Society.

24 Mar 2014

Researchers estimate that around 1 million children suffer from TB annually

Researchers from Brigham and Women's Hospital and Harvard Medical School in Boston have estimated that around one million children suffer from tuberculosis (TB) annually- twice the number previously thought to have tuberculosis and three times the number that are diagnosed every year.

24 Mar 2014

GHIT Fund announces grants to speed up innovative drug development for neglected diseases

The Global Health Innovative Technology Fund, a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, today announced three grants worth a total of US$6.8 million to speed the development of innovative drugs for some of the world’s most neglected diseases—schistosomiasis, Chagas disease and parasitic roundworms.

20 Mar 2014

LSTM and University of Liverpool receive GHIT Fund to target lymphatic filariasis and onchocerciasis

The Liverpool School of Tropical Medicine (LSTM) together with colleagues at the Department of Chemistry (University of Liverpool (UoL)) and Japanese pharmaceutical company Eisai are pleased to announce that they have been awarded a Global Health Innovative Technology (GHIT) Fund to develop new drugs to target lymphatic filariasis and onchocerciasis.

20 Mar 2014

Research finds youth, wealth and education to be risk factors linked with violent radicalisation

New research from Queen Mary University of London has found youth, wealth, and being in full-time education to be risk factors associated with violent radicalisation. Contrary to popular views - religious practice, health and social inequalities, discrimination, and political engagement showed no links.

19 Mar 2014

Strengthening health systems is the most critical investment in global health, finds survey

Strengthening the health systems that provide health products and care is the most critical investment in global health, according to international survey results released today by leading global health organizations, PSI and PATH, as well as Devex, the global development media brand.

19 Mar 2014

Study suggests that non-communicable diseases can be programmed before birth

A new study in mothers and children of Pakistani origin suggests non-communicable diseases such as cardiovascular disease and Type 2 Diabetes could be programmed prior to birth.

17 Mar 2014

Notre Dame biologists awarded $23M research grant to prevent malaria and dengue fever

Notre Dame biologists Nicole Achee and Neil Lobo are leaders of an international $23 million research grant from the Bill & Melinda Gates Foundation. Their five-year project will generate the data required to show the effectiveness of a new paradigm in mosquito control -spatial repellency - for the prevention of two important mosquito-borne diseases: malaria and dengue fever.

13 Mar 2014

EPFL sets up foundation to release antibiotic for tuberculosis

Even though tuberculosis kills more than 1.5 million people every year, the market is not cost-effective for pharmaceutical companies. So EPFL is setting up a foundation to release an antibiotic developed in its own laboratories under EU funding.

12 Mar 2014

Global Health News and Research

CDC receives 2014 Franz Edelman Award for Achievement in Operations Research, Management Sciences

MADIT-CRT study: Boston Scientific CRT defibrillator reduces risk of death in mild heart failure patients

Nordion enters into definitive agreement to be acquired by Sterigenics

New policy report on multi-drug resistant tuberculosis

Economic growth has little to no effect on nutritional status of world's poorest children

ASU scientist selected as 2014 recipient of Lifetime Achievement Award

WHO report confirms air pollution as world's largest single environmental health risk

IDRI awarded grant extension of $3.4M for identifying new leads and drug targets for tuberculosis

Tuberculosis control needs a complete and patient-centric solution

New national research consortium focuses on better drug therapies for viral infections

Researchers developing new medication to tackle river blindness and elephantiasis

Study: Mood stabilizing drug may help prevent head and neck cancer

Researchers estimate that around 1 million children suffer from TB annually

GHIT Fund announces grants to speed up innovative drug development for neglected diseases

LSTM and University of Liverpool receive GHIT Fund to target lymphatic filariasis and onchocerciasis

Research finds youth, wealth and education to be risk factors linked with violent radicalisation

Strengthening health systems is the most critical investment in global health, finds survey

Study suggests that non-communicable diseases can be programmed before birth

Notre Dame biologists awarded $23M research grant to prevent malaria and dengue fever

EPFL sets up foundation to release antibiotic for tuberculosis

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News